نتایج جستجو برای: nucleoside rt inhibitor

تعداد نتایج: 279418  

2017
Fuu-Jen Tsai Chi-Fung Cheng Chih-Ho Lai Yang-Chang Wu Mao-Wang Ho Jen-Hsien Wang Ni Tien Xiang Liu Hsinyi Tsang Ting-Hsu Lin Chiu-Chu Liao Shao-Mei Huang Ju-Pi Li Jung-Chun Lin Chih-Chien Lin Jin-Hua Chen Wen-Miin Liang Ying-Ju Lin

HIV-infected patients exposed to antiretroviral therapy (ART) have an increased risk for hyperlipidemia and cardiovascular disease. We performed a longitudinal, comprehensive, and population-based study to investigate the cumulative effect of different types of ART regimens on hyperlipidemia risk in the Taiwanese HIV/ART cohort. A total of 13,370 HIV-infected patients (2,674 hyperlipidemia and ...

2015
Alessandro Cozzi-Lepri Marc Noguera-Julian Francesca Di Giallonardo Rob Schuurman Martin Däumer Sue Aitken Francesca Ceccherini-Silberstein Antonella D'Arminio Monforte Anna Maria Geretti Clare L. Booth Rolf Kaiser Claudia Michalik Klaus Jansen Bernard Masquelier Pantxika Bellecave Roger D. Kouyos Erika Castro Hansjakob Furrer Anna Schultze Huldrych F. Günthard Francoise Brun-Vezinet Roger Paredes Karin J. Metzner Roger Paredes Karin J. Metzner Alessandro Cozzi-Lepri Rob Schuurman Francoise Brun-Vezinet Huldrych Günthard Francesca Ceccherini-Silberstein Rolf Kaiser Anna Maria Geretti Norbert Brockmeyer Bernard Masquelier F. Dabis M. Bruyand G. Chêne S. Lawson-Ayayi R. Thiébaut L. Wittkop K. André F. Bonnal F. Bonnet N. Bernard L. Caunègre C. Cazanave J. Ceccaldi I. Chossat K. Courtaud F. A. Dauchy S. De Witte M. Dupon A. Dupont P. Duffau H. Dutronc S. Farbos V. Gaborieau M. C. Gemain Y. Gerard C. Greib M. Hessamfar D. Lacoste P. Lataste E. Lazaro M. Longy-Boursier D. Malvy J. P. Meraud P. Mercié E. Monlun P. Morlat D. Neau A. Ochoa J. L. Pellegrin T. Pistone M. C. Receveur J. Roger Schmeltz S. Tchamgoué M. A. Vandenhende M.O. Vareil J. F. Viallard J. F. Moreau I. Pellegrin H. Fleury M. E. Lafon B. Masquelier S. Reigadas P. Trimoulet S. Bouchet D. Breilh M. Molimard K. Titier F. Haramburu G. Miremont-Salamé. M. J. Blaizeau M. Decoin J. Delaune S. Delveaux C. D'Ivernois C. Hanapier O. Leleux E. Lenaud B. Uwamaliya-Nziyumvira X. Sicard S. Geffard F. Le Marec V. Conte A. Frosch J. Leray G. Palmer D. Touchard M. Losso M. Kundro J. M. Ramos Mejia N. Vetter R. Zangerle I. Karpov A. Vassilenko V. M. Mitsura O. Suetnov N. Clumeck S. De Wit M. Delforge E. Florence L. Vandekerckhove V. Hadziosmanovic K. Kostov J. Begovac L. Machala D. Jilich D. Sedlacek J. Nielsen G. Kronborg T. Benfield M. Larsen J. Gerstoft T. Katzenstein A.-B. E. Hansen P. Skinhøj C. Pedersen L. Ostergaard U. B. Dragsted L. N. Nielsen K. Zilmer Jelena Smidt M. Ristola C. Katlama J. P. Viard P. M. Girard P. Vanhems C. Pradier C. Duvivier J. Rockstroh R. Schmidt J. van Lunzen O. Degen H. J. Stellbrink M. Bickel J. Bogner G. Fätkenheuer J. Kosmidis P. Gargalianos G. Xylomenos J. Perdios H. Sambatakou D. Banhegyi M. Gottfredsson F. Mulcahy I. Yust D. Turner M. Burke S. Pollack G. HassounRambam H. Elinav M. HaouziHadassah R. EspositoI F. Mazzotta V. Vullo M. Moroni M. Andreoni G. Angarano A. Antinori F. Castelli R. Cauda G. Di Perri M. Galli R. Iardino G. Ippolito A. Lazzarin C. F. Perno F. von Schloesser P. Viale A. D'Arminio Monforte A. Castagna F. Ceccherini-Silberstein A. Cozzi-Lepri E. Girardi S. Lo Caputo C. Mussini M. Puoti A. Ammassari C. Balotta P. Bonfanti S. Bonora M. Borderi M. R. Capobianchi A. Cingolani P. Cinque A. De Luca A. Di Biagio N. Gianotti A. Gori G. Guaraldi G. Lapadula M. Lichtner G. Madeddu F. Maggiolo G. Marchetti S. Marcotullio L. Monno E. Quiros Roldan S. Rusconi P. Cicconi I. Fanti T. Formenti L. Galli P. Lorenzini F. Carletti S. Carrara A. Castrogiovanni A. Di Caro F. Petrone G. Prota S. Quartu A. Giacometti A. Costantini S. Mazzoccato C. Santoro C. Suardi E. Vanino G. Verucchi C. Minardi T. Quirino C. Abeli P. E. Manconi P. Piano J. Vecchiet K. Falasca L. Sighinolfi D. Segala G. Cassola C. Viscoli A. Alessandrini R. Piscopo G. Mazzarello C. Mastroianni V. Belvisi I. Caramma A. Chiodera A. P. Castelli G. Rizzardini A. D'Arminio Monforte A. L. Ridolfo R. Piolini S. Salpietro L. Carenzi M. C. Moioli C. Tincati C. Puzzolante N. Abrescia A. Chirianni M. G. Guida M. Gargiulo F. Baldelli D. Francisci G. Parruti T. Ursini G. Magnani M. A. Ursitti A. d'Avino L. Gallo E. Nicastri R. Acinapura M. Capozzi R. Libertone G. Tebano A. Cattelan L. Sasset M. S. Mura B. Rossetti P. Caramello G. C. Orofino M. Sciandra M. Bassetti A. Londero G. Pellizzer V. Manfrin N. H. Brockmeyer A. Skaletz-Rorowski S. Dupke A. Baumgarten A. Carganico S. Köppe P. Kreckel E. Lauenroth-Mai M. Freiwald-Rausch J. Gölz A. Moll M. Zeitz M. Hower S. Reuter B. Jensen T. Harrer S. Esser H. R. Brodt A. Plettenberg A. Stöhr T. Buhk M. Stoll B. Kuhlmann F. A. Mosthaf A. Rieke W. Becker R. Volkert H. Jäger H. Hartl A. Mutz A. Ulmer M. Müller V. Aubert J. Barth M. Battegay E. Bernasconi J. Böni H. C. Bucher C. Burton-Jeangros A. Calmy M. Cavassini M. Egger L. Elzi J. Fehr J. Fellay H. Furrer C. A. Fux M. Gorgievski H. Günthard D. Haerry B. Hasse H. H. Hirsch I. Hösli C. Kahlert L. Kaiser O. Keiser T. Klimkait H. Kovari R. Kouyos B. Ledergerber G. Martinetti B. Martinez de Tejada K. Metzner N. Müller D. Nadal G. Pantaleo A. Rauch S. Regenass M. Rickenbach C. Rudin P. Schmid D. Schultze F. Schöni-Affolter J. Schüpbach R. Speck C. Staehelin P. Tarr A. Telenti A. Trkola P. Vernazza R. Weber S. Yerly

OBJECTIVES It is still debated if pre-existing minority drug-resistant HIV-1 variants (MVs) affect the virological outcomes of first-line NNRTI-containing ART. METHODS This Europe-wide case-control study included ART-naive subjects infected with drug-susceptible HIV-1 as revealed by population sequencing, who achieved virological suppression on first-line ART including one NNRTI. Cases experi...

Journal: :The Journal of biological chemistry 1996
S F O'Handley D N Frick L C Bullions A S Mildvan M J Bessman

The product of the Escherichia coli orf17 gene is a novel nucleoside triphosphate pyrophosphohydrolase with a preference for dATP over the other canonical (deoxy)nucleoside triphosphates, and it catalyzes the hydrolysis of dATP through a nucleophilic attack at the beta-phosphorus to produce dAMP and inorganic pyrophosphate. It has a pH optimum between 8.5 and 9.0, a divalent metal ion requireme...

Journal: :American journal of physiology. Renal physiology 2007
Vijaya L Damaraju Adam N Elwi Charlene Hunter Pat Carpenter Cheryl Santos Gerry M Barron Xuejun Sun Stephen A Baldwin James D Young John R Mackey Michael B Sawyer Carol E Cass

Nucleoside transporters in kidney mediate renal reabsorption and secretion of nucleosides. Using RT-PCR, we demonstrated mRNAs encoding hENT1, hENT2, hCNT1, hCNT2, and hCNT3 in both cortex and medulla. Immunoblotting with crude membrane preparations revealed abundant hENT1 and hCNT3 in both cortex and medulla, and little, if any, hENT2, hCNT1, or hCNT2, indicating that the latter were either ab...

Journal: :The Journal of infectious diseases 2010
Jeffrey A Canter Gregory K Robbins Doug Selph David B Clifford Asha R Kallianpur Robert Shafer Shawn Levy Deborah G Murdock Marylyn D Ritchie David W Haas Todd Hulgan

Susceptibility to peripheral neuropathy during antiretroviral therapy with nucleoside reverse-transcriptase inhibitors was previously associated with a European mitochondrial DNA (mtDNA) haplogroup among non-Hispanic white persons. To determine whether nucleoside reverse-transcriptase inhibitor-associated peripheral neuropathy was related to mtDNA variation in non-Hispanic black persons, we seq...

Journal: :Antimicrobial agents and chemotherapy 2007
Nicolas Sluis-Cremer Chih-Wei Sheen Shannon Zelina Pedro S Argoti Torres Urvi M Parikh John W Mellors

The K70E mutation in human immunodeficiency virus type 1 (HIV-1) reverse transcriptase (RT) has become more prevalent in clinical samples, particularly in isolates derived from patients for whom triple-nucleoside regimens that include tenofovir (TNV), abacavir, and lamivudine (3TC) failed. To elucidate the molecular mechanism by which this mutation confers resistance to these nucleoside RT inhi...

2013
David W. Wright Ilona P. Deuzing Philippe Flandre Peter van den Eede Micheline Govaert Laurentia Setiawan Peter V. Coveney Anne-Geneviève Marcelin Vincent Calvez Charles A. B. Boucher Nancy Beerens

Reverse transcriptase (RT) plays an essential role in HIV-1 replication, and inhibition of this enzyme is a key component of HIV-treatment. However, the use of RT inhibitors can lead to the emergence of drug-resistant variants. Until recently, most clinically relevant resistance mutations were found in the polymerase domain of RT. Lately, an increasing number of resistance mutations has been id...

2015

Submit Manuscript | http://medcraveonline.com Abbreviations: ART: Antiretroviral Therapy; NNRTI: NonNucleoside Reverse Transcriptase Inhibitor; NRTI: Nucleoside/N Ucleotide Reverse Transcriptase Inhibitor; PI: Protease Inhibitor; AZT: Zidovudine; D4T: Stavudine; DDI: Didanosine; TDF: Tenofovir Disoproxil Fumarate; EFV: Efavirenz; NVP: Nevirapine; ETR: Etravirine; LPV/R: Lopinavir and Ritonavir;...

2016
Guillermo Villegas Giulia Calenda Shweta Ugaonkar Shimin Zhang Larisa Kizima Olga Mizenina Agegnehu Gettie James Blanchard Michael L. Cooney Melissa Robbiani José A. Fernández-Romero Thomas M. Zydowsky Natalia Teleshova

Women need multipurpose prevention products (MPTs) that protect against sexually transmitted infections (STIs) and provide contraception. The Population Council has developed a prototype intravaginal ring (IVR) releasing the non-nucleoside reverse transcriptase inhibitor (NNRTI) MIV-150 (M), zinc acetate (ZA), carrageenan (CG) and levonorgestrel (LNG) (MZCL IVR) to protect against HIV, HSV-2, H...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید